Chemical sensitivity and fatigue syndromes from hypoxia/hypercapnia

Medical Hypotheses

Volumn 54, Issue 5, 2000, Pages 734-738

  Ross, P M ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORGANIC SOLVENT; PESTICIDE;

AIRWAY OBSTRUCTION; BREATHING DISORDER; FATIGUE; HEADACHE; HYPERCAPNIA; HYPOXIA; INFLAMMATION; MULTIPLE CHEMICAL SENSITIVITY; NEUROTOXICITY; PRIORITY JOURNAL; REVIEW; SLEEP APNEA SYNDROME; UPPER RESPIRATORY TRACT;

CACOSMIA; PROTEA;

EID: 0034081494     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1999.0942     Document Type: Article

References (57)

1. Cullen M. R. The worker with multiple chemical sensitivities. Cullen M. R. Occupational Medicine: state of the art reviews: workers with multiple chemical sensitivities. 1987;Hanley and Belfus, Philadelphia.
2. Gupta K., Perharic L., Volans G. N., Murray V. S., Watson J. P. Apparent poisoning by wood preservatives: an attributional syndrome. J Psychosomatic Res. 43:1997;391-398.
3. Staudenmeyer H., Selner J. C., Buhr M. P. Double-blind provocation chamber challenges in 20 patients presenting with 'Multiple Chemical Sensitivity'. Regal Toxicol Pharmacol. 18:1993;44-53.
4. Jewett D. L., Fein G., Greenberg M. H. A double-blind study of symptom provocation to determine food sensitivity. N Engl J Med. 323:1990;430-433.
5. Tollefson L. Multiple chemical sensitivity: controlled scientific studies as proof of causation. Regul Toxicol Pharmacol. 18:1993;32-43.
6. Hummel T., Roscher S., Jaumann M. N., Kobal G. Intranasal chemoreception in patients with multiple chemical sensitivities: a double-blind investigation. Regul Toxicol Pharmacol. 24:1996;S79-S86.
7. Leznoff A. Provocative challenges in patients with multiple chemical sensitivity. J Allergy Clin Immunol. 99:1997;438-442.
8. Ashford, N. A. Miller, C. S. Chemical Exposures: Low levels and High Stakes. New York, Van Nostrand Reinhhold, 1991.
9. Fiedler N. An overview of the symptoms of multiple chemical sensitivities. Neth J Medicine. 93:1996;39-42.
10. Corrigan F. M., MacDonald S., Brown A., Armstrong K., Armstrong E. M. Neurasthenic fatigue, chemical sensitivity, and GABAa receptor toxins. Med Hypotheses. 43:1994;195-200.
11. Doty R. L., Deems D. A., Frye R. E., Pelberg R., Shapiro A. Olfactory sensitivity, nasal resistance, and autonomic function in patients with multiple chemical sensitivities. Arch Otolaryngol Head Neck Surg. 114:1988;1422-1427.
12. Meggs W. J., Cleveland C. H. Rhinolaryngoscopic examination of patients with the multiple chemical sensitivity syndrome. Arch Environ Health. 48:1993;14-18.
13. Meggs W. J., Cleveland C. H., Metzger W. J., Larkin E. L., Albernaz M. Reactive upper-airways dysfunction syndrome (RUDS). A form of irritant rhinitis induced by a chemical exposure. J Allergy Clin Immunol. 170:1992;104.
14. Bell I. R. White paper: neuropsychiatric aspects of sensitivity to low-level chemicals: a neural sensitization model. Toxicol Ind Health. 10:1994;277-312.
15. Bell I. R., Miller C. S., Schwartz G. E. An olfactory-limbic model of multiple chemical sensitivity syndrome: possible relationships to kindling and affective spectrum disorders. Biol Psychiatry. 32:1992;218-242.
16. Bascom R. Multiple chemical sensitivity: a respiratory disorder? Multiple Chemical Sensitivity: a scientific overview. 1994;USPHS/ATSDR, p. 221-228.
17. Meggs W. J. Neurogenic Switching: A hypothesis for a mechanism for shifting the site of inflammation in allergy and chemical sensitivity. Environ Health Perspect. 103:1995;54-56.
18. Chester A. C. Sick-building syndrome fatigue as a possible predation defense. Integr Physiol Behav Sci. 30:1995;68-83.
19. Simon G. E., Daniell W., Stockbridge H., Claypoole K., Rosenstock L. Immunologic, psychological and neurophysiological factors in multiple chemical sensitivity. Ann Int Med. 119:1993;97-103.
20. Ross P. M., Whysner J., Covello V. T. Olfaction and the multiple chemical sensitivities syndrome. Prev Med. 28:1999;467-480.
21. Slotkoff A. T., Radulovic D. A., Clauw D. J. The relationship between fibromyalgia and the multiple chemical sensitivity syndrome. Scand J Rheumatol. 26:1997;364-367.
22. Chester A. C. Chronic fatigue cured by nasal surgery. Md Med J. 42:1993;365-367.
23. Jennum P., Hein H. O., Suadicani P., Gyntelberg F. Headache and cognitive dysfunctions in snorers. Arch Neurol. 51:1994;937-942.
24. Ulfberg J. Snoring and headache: an important association. Arch Neurol. 52:1995;1043.
25. Poceta J. S., Dalession D. J. Identification and treatment of sleep apnea in patients with chronic headache. Headache. 35:1995;586-589.
26. Paiva T., Batista A., Martins P., Martins A. The relationship between headaches and sleep disturbances. Headache. 35:1995;590-596.
27. McComas A. J., Miller R. G., Gandevia S. C. Fatigue brought on by malfunction of the central and peripheral nervous systems. Gandevia S. C. Fatigue. 1995;Plenum Press, New York.
28. Buchwald D., Pascualy R., Bombardier C., Kith P. Sleep Disorders in patients with chronic fatigue. Clin Infect Dis. 18:1994;C68-S72.
29. Olson L. G., King M. T., Hensley M. J., Saunders N. A. A community study of snoring and sleep-disordered breathing. Symptoms. Am J Resp and Crit Care Med. 152:1995;707-710.
30. Bell I. R. Clinically relevant EEG studies and psychophysiological findings: possible neural mechanisms for multiple chemical sensitivity. Toxicology. 111:1996;101-117.
31. Bell I. R., Bootizn R. R., Ritenbaugh C. A polysomnographic study of sleep disturbance in community elderly with self-reported environmental chemical odor intolerance. Biol Psychiatry. 40:1996;123-133.
32. Olsen K. D., Kern E. B., Westbrook P. R. Sleep and breathing disturbance secondary to nasal obstruction. Otolaryngol Head Neck Surg. 89:1981;804-810.
33. Warren D. W., Odont D., Walker J. C., Drake A. F., Lutz R. W. Effects of odorants and irritants on respiratory behavior. Laryngoscope. 104:1994;623-626.
34. Nielsen G. D. Mechanisms of activation of the sensory irritant receptor by airborne chemicals. Crit Rev Toxicol. 21:1991;183-208.
35. Krupp L. B., Jandorf L., Coyle P. K., Mendelson W. B. Sleep disturbance in chronic fatigue syndrome. J Psychosomat Res. 37:1993;325-331.
36. Morriss R. Insomnia in the chronic fatigue syndrome. BMJ. 307:1993;264.
37. Morriss R., Sharpe M., Sharpley A. L., Cowen P. J., Hawton K., Morris J. Abnormalities of sleep in patients with the chronic fatigue syndrome. BMJ. 306:1993;1161-1164.
38. Manu P., Lane T. J., Matthews D. A., Castriotta R. J., Watson R. K., Abeles M. Alpha-delta sleep in patients with chief complaint of chronic fatigue. South Med J. 87:1994;461-470.
39. Gill J., Feldman N. T. Sleep disorders and chronic fatigue. South Med J. 87:1994;1289-1290.
40. Fiedler N., Kipen H., Deluca J., Kelly-McNeil K., Natelson B. Neuropsychology and psychology of MCS. Toxicol Ind Health. 10:1994;545-554.
41. Morrow L. A., Steinhauer S., Morrow R., Ryan C. M. The utility of psychophysiological measures in assessing the correlates and consequences of organic solvent exposure. Toxicol Ind Health. 10:1994;537-544.
42. Lorig T. S. EEG and ERP studies of low-level odor exposure in normal subjects. Toxicol Ind Health. 10:1994;579-586.
43. Behan P., Hanifah B. A. G. Chronic fatigue syndrome: a possible delayed hazard of pesticide exposure. Clin Infect Dis. 18:1994;S54-S55.
44. Monstad P., Mellgren S. I., Sulg I. A. The clinical significance of sleep apnoea in workers exposed to organic solvents: implications for the diagnosis of organic solvent encephalopathy. J Neurol. 239:1992;195-198.
45. Fiedler N., Kipen H. Chemical sensitivity: The scientific literature. Env Health Persp. 105:1997;409-415.
46. Johnson S. K., de Luca J., Fiedler N., Natelson B. H. Cognitive function of patients with chronic fatigue syndrome. Clin Infect Dis. 18:1994;S84-S85.
47. Feuerstein C., Naegele B., Pepin J. L., Levy P. Frontal lobe-related cognitive functions in patients with sleep apnea syndrome before and after treatment. Acta Neurol Belg. 97:1997;96-107.
48. Chester A. C. Nasal dilator for management of sleep apnea. Am J Otolaryngol. 13:1992;250.
49. Fairbanks D. Nonsurgical treatment of snoring and obstructive sleep apnea. Otolaryngol Head Neck Surg. 100:1989;633-635.
50. McKlellan R. K. Biological interventions in the treatment of patients with multiple chemical sensitivities. Occup Med. 2:1987;755-777.
51. Bolla-Wilson K., Wilson R. J., Bleeker M. Conditioning of physical symptoms after neurotoxic exposures. J Occup Med. 30:1988;684-686.
52. Spyker D. A. Multiple Chemical Sensitivities - syndrome and solution. Clin Toxicol. 33:1995;95-99.
53. Randolph, T. G. Moss, R. W. Alternative approach to Allergies. New York, Harper and Row, 1990.
54. Rajagopol K. R., Bennett L. L., Dillard T. A., Tellis C. H., Tenholder M. F. Overnight CPAP improves hypersomnolence in sleep apnea. Chest. 90:1986;172-176.
55. Schenck C. H., Hurwitz T. D., O'Connor K. A., Mahowald M. W. Additional categories of sleep-related eating disorders and the current status of treatment. Sleep. 16:1993;457-466.
56. Issa F. G., Sullivan C. E. Reversal of Central Sleep Apnea using nasal CPAP. Chest. 90:1986;165-171.
57. Gothe C.-J., Odont D., Nilsson C. G. The environmental somatization syndrome. Psychosomatics. 36:1995;1-11.